Signaturefd, LLC Arcus Biosciences, Inc. Transaction History

Signaturefd, LLC

$5.2 Billion
Q3 2024

A detailed history of Signaturefd, LLC transactions in Arcus Biosciences, Inc. stock. As of the latest transaction made, Signaturefd, LLC holds 40 shares of RCUS stock, worth $561. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Holding current value

$561

% of portfolio

0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	BUY	$13.69 - $18.01 $547 - $720	40 New	40 $0
Q1 2024 May 03, 2024	BUY	$14.83 - $20.18 $370 - $504	25 Added 59.52%	67 $1,000
Q4 2023 Jan 31, 2024	SELL	$13.43 - $19.63 $241 - $353	-18 Reduced 30.0%	42 $0
Q3 2023 Nov 03, 2023	BUY	$17.62 - $23.54 $528 - $706	30 Added 100.0%	60 $1,000
Q2 2023 Aug 01, 2023	SELL	$16.97 - $22.03 $780 - $1,013	-46 Reduced 60.53%	30 $0
Q1 2023 Apr 28, 2023	BUY	$15.96 - $23.15 $1,021 - $1,481	64 Added 533.33%	76 $1,000
Q4 2022 Jan 27, 2023	SELL	$19.7 - $35.71 $19 - $35	-1 Reduced 7.69%	12 $0
Q3 2022 Nov 08, 2022	BUY	$23.23 - $30.07 $301 - $390	13 New	13 $0
Q2 2022 Aug 10, 2022	SELL	$17.23 - $37.73 $447 - $980	-26 Closed	0 $0
Q4 2021 Jan 25, 2022	BUY	$31.38 - $48.47 $815 - $1,260	26 New	26 $1,000
Q3 2021 Oct 28, 2021	SELL	$26.93 - $37.68 $700 - $979	-26 Closed	0 $0
Q2 2021 Jul 26, 2021	SELL	$22.75 - $35.77 $2,002 - $3,147	-88 Reduced 77.19%	26 $1,000
Q1 2021 Apr 30, 2021	BUY	$26.16 - $41.39 $2,982 - $4,718	114 New	114 $3,000

Others Institutions Holding RCUS

# of Institutions

200

Shares Held

51.5M

Call Options Held

236K

Put Options Held

141K

Black Rock Inc. New York, NY

9.76M
Shares

$137 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

5.47M
Shares

$76.7 Million
0.0% of portfolio
Woodline Partners LP San Francisco, CA

3.48M
Shares

$48.8 Million
0.48% of portfolio
State Street Corp Boston, MA

3.01M
Shares

$42.2 Million
0.0% of portfolio
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct

2.44M
Shares

$34.2 Million
0.1% of portfolio

View Full List

About Arcus Biosciences, Inc.

Ticker RCUS
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 72,160,000
Market Cap $1.01B
Description
Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 antibody that is in Phase 1b clinical trial for ...

More about RCUS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.

Account